Liver-Directed Adenoviral Gene Transfer in Murine Succinate Semialdehyde Dehydrogenase Deficiency
Open Access
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (4) , 527-539
- https://doi.org/10.1016/j.ymthe.2004.01.013
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (Gamma-Hydroxybutyric aciduria)Biological Psychiatry, 2003
- Murine succinate semialdehyde dehydrogenase deficiencyAnnals of Neurology, 2003
- Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1aEuropean Journal of Pediatrics, 2002
- Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenaseNature Genetics, 2001
- Gene therapy for neurodegenerative diseases: fact or fiction?The British Journal of Psychiatry, 2001
- Adenovirus-mediated Gene Therapy of Liver DiseasesSeminars in Liver Disease, 1999
- 4-Hydroxybutyric Acid and the Clinical Phenotype of Succinic Semialdehyde Dehydrogenase Deficiency, an Inborn Error of GABA MetabolismNeuropediatrics, 1998
- Adenovirus-Mediated Gene Therapy in a Mouse Model of Hereditary Tyrosinemia Type IHuman Gene Therapy, 1997
- Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 1995
- VIGABATRIN THERAPY IN PATIENT WITH SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCYThe Lancet, 1989